Cancer drug sitravatinib tested for Long-Term use in advanced tumors
NCT ID NCT04887870
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 26 times
Summary
This study followed 52 people with advanced or metastatic solid tumors who were already benefiting from sitravatinib treatment in an earlier study. The main goal was to track side effects over time. Participants continued their current sitravatinib regimen (alone or with other drugs) as long as they were tolerating it and their doctor felt it was in their best interest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SOLID MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Local Institution - 516-014-001
Austin, Texas, 78758, United States
-
Local Institution - 516-014-002
Boston, Massachusetts, 02215, United States
-
Local Institution - 516-014-004
Columbus, Ohio, 43210, United States
-
Local Institution - 516-014-005
Minneapolis, Minnesota, 55455, United States
-
Local Institution - 516-014-011
Albany, New York, 12208, United States
-
Local Institution - 516-014-013
Houston, Texas, 77030, United States
-
Local Institution - 516-014-029
Goshen, Indiana, 46526, United States
-
Memorial Sloan Kettering Cancer Center - Arnold and Marie Schwartz Cancer Research Building
New York, New York, 10065, United States
-
NEXT Virginia
Fairfax, Virginia, 22031, United States
-
Rocky Mountain Cancer Centers - Littleton
Littleton, Colorado, 80218, United States
-
USOR - Texas Oncology Northeast Texas - Denison
Denison, Texas, 75020, United States
-
Urology Cancer Center and GU Research Network
Omaha, Nebraska, 68130, United States
Conditions
Explore the condition pages connected to this study.